Please assess the completion status of the following clinical trial:

Trial Title: Vitamin D Supplementation in HIV Youth

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ages 8-25~* Documented HIV-1 infection~* On stable antiretroviral therapy for \> 3 months~* Cumulative antiretroviral therapy of at least 6 months~* 25(OH)D level \< 30 ng/ml at screening~Exclusion Criteria:~* \> 400 IU daily regular vitamin D intake~* Parathyroid/calcium disorders~* Active malignancy~* Pregnancy/intent to become pregnant/breastfeeding~* Chronic infectious/inflammatory conditions~* Creatinine clearance \< 50 ml/min~* Hemoglobin \< 9.0 g/dL~* Aspartate aminotransferase and alanine aminotransferase \> 2.5 upper limit of normal~* Diabetes requiring hypoglycemic agents~* Known coronary artery disease~* Inability to swallow pills

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 25 Years
- Healthy Volunteers: t

Study Arms:
- HIV + Young Adults (Type: ACTIVE_COMPARATOR): All will be HIV+ and receiving randomized dose of vitamin D control dose (low dose) or supplementation dose (vitamin D medium dose or vitamin D high dose)
- HIV - Controls (Type: ACTIVE_COMPARATOR): HIV negative controls will be receiving randomized Vitamin D doses: control vitamin D dose (low dose) or vitamin D supplementation dose (vitamin D medium dose or vitamin D high dose)

Based on this trial design, predict the completion outcome and termination type (if applicable).